SGI
LJPC

Summit Global Investments’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Summit Global Investments’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-48,500
Closed -$208K – 593
2021
Q2 		$208K Buy
+48,500
New +$208K 0.01% 530

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Summit Global Investments's LJPC Position: Q3 2021 in Review

Summit Global Investments sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 48,500 shares — an estimated $208K sold.

Summit Global Investments first reported a position in LJPC in Q2 2021 and held it in 1 quarter. The position peaked at $208K in Q2 2021. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Summit Global Investments reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Summit Global Investments sold 48,500 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $208K.
  • Summit Global Investments first reported a position in La Jolla Pharmaceutical Company in Q2 2021 and held it in 1 quarter.
  • Summit Global Investments's La Jolla Pharmaceutical Company position peaked at $208K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Summit Global Investments's 13F filing for Q3 2021, filed 8 Nov 2021.